-
Apr.282023NEWS
HanAll Biopharma Reports First Quarter 2023 Results and Provides Business Update
HanAll Biopharma Reports First Quarter 2023 Results and Provides Business Update
-
Mar.292023NEWS
HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next Phase of Growth
HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next Phase of Growth
-
Mar.152023NEWS
HanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Program
HanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Program
-
Mar.152023NEWS
HanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Program
HanAll Biopharma Opens Applications for the 2023 Pharmaceutical Industry Fellowship Program
-
Mar.062023NEWS
HanAll Biopharma’s Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis
HanAll Biopharma’s Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclim..
-
Feb.022023NEWS
HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities
HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities